MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells

Carcinogenesis

Volumn 31, Issue 6, 2010, Pages 1037-1044

  Pang, Ronald T K ^a   Leung, Carmen O N ^a   Ye, Tian Min ^a   Liu, Weimin ^a   Chiu, Philip C N ^a   Lam, Kevin K W ^a   Lee, Kai Fai ^a   Yeung, William S B ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA SECRETASE INHIBITOR; JAGGED1; MICRORNA; MICRORNA 34A; NOTCH1 RECEPTOR; TRANSCRIPTION FACTOR HES 1; UNCLASSIFIED DRUG; UROKINASE; CALCIUM BINDING PROTEIN; MEMBRANE PROTEIN; MIRN34 MICRORNA, HUMAN; NOTCH1 PROTEIN, HUMAN; SERRATE PROTEINS; SIGNAL PEPTIDE;

3' UNTRANSLATED REGION; ARTICLE; BEWO CELL; C33A CELL; C41 CELL; CANCER CELL; CANCER INHIBITION; CANCER INVASION; CARCINOMA CELL; CASKI CELL; CELL PROLIFERATION; CHORIOCARCINOMA; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; JAR CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REGULATORY MECHANISM; RNA INTERFERENCE; SIHA CELL; TROPHOBLAST; UTERINE CERVIX CARCINOMA; FEMALE; GENE SILENCING; GENETICS; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; UTERINE CERVIX TUMOR; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; BLOTTING, WESTERN; CALCIUM-BINDING PROTEINS; CELL LINE, TUMOR; CHORIOCARCINOMA; DOWN-REGULATION; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICRORNAS; NEOPLASM INVASIVENESS; RECEPTOR, NOTCH1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UTERINE CERVICAL NEOPLASMS;

EID: 77953920780     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq066     Document Type: Article

References (61)

1. Denli, A.M. et al. (2004) Processing of primary microRNAs by the Microprocessor complex. Nature, 432, 231-235.
2. Berezikov, E. et al. (2005) Phylogenetic shadowing and computational identification of human microRNA genes. Cell, 120, 21-24.
3. Mikkola, H.K. et al. (2006) The journey of developing hematopoietic stem cells. Development, 133, 3733-3744.
4. Sporn, M.B. (1996) The war on cancer. Lancet, 347, 1377-1381.
5. Baranwal, S. et al. (2009) miRNA control of tumor cell invasion and metastasis. Int. J. Cancer, 126, 1283-1290.
6. Dalmay, T. et al. (2006) MicroRNAs and the hallmarks of cancer. Oncogene, 25, 6170-6175.
7. Dutta, K.K. et al. (2007) Association of microRNA-34a overexpression with proliferation is cell type-dependent. Cancer Sci., 98, 1845-1852.
8. He, L. et al. (2007) microRNAs join the p53 network-another piece in the tumour-suppression puzzle. Nat. Rev. Cancer, 7, 819-822.
9. He, L. et al. (2007) A microRNA component of the p53 tumour suppressor network. Nature, 447, 1130-1134.
10. Tazawa, H. et al. (2007) Tumor-suppressive miR-34a induces senescencelike growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc. Natl Acad. Sci. USA, 104, 15472-15477.
11. Raver-Shapira, N. et al. (2007) Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol. Cell, 26, 731-743.
12. Chang, T.C. et al. (2007) Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell, 26, 745-752.
13. Yamakuchi, M. et al. (2008) miR-34a repression of SIRT1 regulates apoptosis. Proc. Natl Acad. Sci. USA, 105, 13421-13426.
14. Tarasov, V. et al. (2007) Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle, 6, 1586-1593.
15. Lewis, B.P. et al. (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 120, 15-20.
16. Welch, C. et al. (2007) MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene, 26, 5017-5022.
17. Cole, K.A. et al. (2008) A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene. Mol. Cancer Res., 6, 735-742.
18. Song, W. et al. (1999) Proteolytic release and nuclear translocation of Notch-1 are induced by presenilin-1 and impaired by pathogenic presenilin1 mutations. Proc. Natl Acad. Sci. USA, 96, 6959-6963.
19. Bolos, V. et al. (2007) Notch signaling in development and cancer. Endocr. Rev., 28, 339-363.
20. Leethanakul, C. et al. (2000) Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays. Oncogene, 19, 3220-3224.
21. Rae, F.K. et al. (2000) Novel association of a diverse range of genes with renal cell carcinoma as identified by differential display. Int. J. Cancer, 88, 726-732.
22. Tohda, S. et al. (2001) Expression of Notch1 and Jagged1 proteins in acute myeloid leukemia cells. Leuk. Lymphoma, 42, 467-472.
23. Wang, Z. et al. (2006) Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. Cancer Res., 66, 2778-2784.
24. Zhang, P. et al. (2008) Critical role of notch signaling in osteosarcoma invasion and metastasis. Clin. Cancer Res., 14, 2962-2969.
25. Bin Hafeez, B. et al. (2009) Targeted knockdown of Notch1 inhibits invasion of human prostate cancer cells concomitant with inhibition of matrix metalloproteinase-9 and urokinase plasminogen activator. Clin. Cancer Res., 15, 452-459.
26. Li, N. et al. (2009) miR-34a inhibits migration and invasion by downregulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Lett., 275, 44-53.
27. Livak, K.J. et al. (2001) Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-408.
28. Iso, T. et al. (2003) HES and HERP families: multiple effectors of the Notch signaling pathway. J. Cell. Physiol., 194, 237-255.
29. Cheung, T.H. et al. (1999) Allelic loss on chromosome 1 is associated with tumor progression of cervical carcinoma. Cancer, 86, 1294-1298.
30. Nagai, H. et al. (1995) Detection and cloning of a common region of loss of heterozygosity at chromosome 1p in breast cancer. Cancer Res., 55, 1752- 1757.
31. Yanada, M. et al. (2005) Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines. Oncol. Rep., 14, 817-822.
32. Ji, Q. et al. (2009) MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One, 4, e6816.
33. zur Hausen, H. (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer, 2, 342-350.
34. Bosch, F.X. et al. (1992) Risk factors for cervical cancer in Colombia and Spain. Int. J. Cancer, 52, 750-758.
35. Scheffner, M. et al. (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 63, 1129-1136.
36. Scheffner, M. et al. (1991) The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl Acad. Sci. USA, 88, 5523- 5527.
37. Werness, B.A. et al. (1990) Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science, 248, 76-79.
38. Wang, X. et al. (2009) Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. RNA, 15, 637- 647.
39. Haidacher, S. et al. (1995) Immunohistochemical evidence of p53 protein in human placenta and choriocarcinoma cell lines. Hum. Reprod., 10, 983-988.
40. Yaginuma, Y. et al. (1995) Analysis of the p53 gene in human choriocarcinoma cell lines. Br. J. Cancer, 71, 9-12.
41. Chen, C.A. et al. (1994) Infrequent mutation in tumor suppressor gene p53 in gestational trophoblastic neoplasia. Carcinogenesis, 15, 2221-2223.
42. Fulop, V. et al. (1998) p53, p21, Rb and mdm2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma. J. Reprod. Med., 43, 119-127.
43. Chen, L. et al. (1998) Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage. Proc. Natl Acad. Sci. USA, 95, 195-200.
44. Grummer, R. et al. (1994) Adhesion and invasion of three human choriocarcinoma cell lines into human endometrium in a three-dimensional organ culture system. Placenta, 15, 411-429.
45. Zhai, Y. et al. (2005) Expression of membrane type 1 matrix metalloproteinase is associated with cervical carcinoma progression and invasion. Cancer Res., 65, 6543-6550.
46. Chatterjee, N. et al. (2001) Role of alphavbeta3 integrin receptor in the invasive potential of human cervical cancer (SiHa) cells. J. Environ. Pathol. Toxicol. Oncol., 20, 211-221.
47. De Falco, M. et al. (2007) Expression and distribution of notch protein members in human placenta throughout pregnancy. Placenta, 28, 118- 126.
48. Cobellis, L. et al. (2007) Distribution of Notch protein members in normal and preeclampsia-complicated placentas. Cell Tissue Res., 330, 527- 534.
49. Daniel, B. et al. (1997) The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions. J. Gen. Virol., 78, 1095-1101.
50. Ramdass, B. et al. (2007) Coexpression of Notch1 and NF-kappaB signaling pathway components in human cervical cancer progression. Gynecol. Oncol., 104, 352-361.
51. Veeraraghavalu, K. et al. (2004) Papillomavirus-mediated neoplastic progression is associated with reciprocal changes in JAGGED1 and manic fringe expression linked to notch activation. J. Virol., 78, 8687-8700.
52. Gallardo, E. et al. (2009) miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. Carcinogenesis, 30, 1903-1909.
53. Westhoff, B. et al. (2009) Alterations of the Notch pathway in lung cancer. Proc. Natl Acad. Sci. USA, 106, 22293-22298.
54. Brennecke, J. et al. (2005) Principles of microRNA-target recognition. PLoS Biol., 3, e85.
55. Shimabukuro, K. et al. (2001) Hepatocyte growth factor/scatter factor is implicated in the mode of stromal invasion of uterine squamous cervical cancer. Gynecol. Oncol., 83, 205-215.
56. Tsai, H.W. et al. (2006) The significance of prohibitin and c-Met/hepatocyte growth factor receptor in the progression of cervical adenocarcinoma. Hum. Pathol., 37, 198-204.
57. Baykal, C. et al. (2003) Overexpression of the c-Met/HGF receptor and its prognostic significance in uterine cervix carcinomas. Gynecol. Oncol., 88, 123-129.
58. Song, L.L. et al. (2008) Notch-1 associates with IKKalpha and regulates IKK activity in cervical cancer cells. Oncogene, 27, 5833-5844.
59. Kobayashi, H. et al. (1994) Impact of urokinase-type plasminogen activator and its inhibitor type 1 on prognosis in cervical cancer of the uterus. Cancer Res., 54, 6539-6548.
60. Sawada, K. et al. (2007) c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion. Cancer Res., 67, 1670-1679.
61. Iiizumi, M. et al. (2008) Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy. Biochim. Biophys. Acta, 1786, 87-104.